These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 6169361)

  • 1. Irritation, staining and antipsoriatic activity of 10-acyl analogues of anthralin.
    Mustakallio KK
    Br J Dermatol; 1981 Aug; 105 Suppl 20():23-7. PubMed ID: 6169361
    [No Abstract]   [Full Text] [Related]  

  • 2. Antipsoriatic activity of 10-acyl analogues of dithranol (anthralin). I. Phase I clinical trial of 10-propionyl dithranol and 10-butyryl dithranol (butantrone).
    Mustakallio KK; Brandt H
    Acta Derm Venereol; 1984; 64(1):63-6. PubMed ID: 6203285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antipsoriatic activity of 10-acyl analogues of dithranol (anthralin). II. Clinical comparison of dithranol and butantrone sticks with special reference to side effects.
    Brandt H
    Acta Derm Venereol; 1987; 67(1):55-61. PubMed ID: 2436415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Irritation and staining by dithranol (anthralin) and related compounds: II. Structure-activity relationships among 10-meso-substituted acyl analogues.
    Mustakallio KK
    Acta Derm Venereol; 1980; 60(2):169-71. PubMed ID: 6155030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Irritation and staining by dithranol (anthralin) and related compounds. V. Short-contact and tape-stripping experiments with dithranol and butantrone.
    Göransson AM; Kolari PJ; Mustakallio KK
    Acta Derm Venereol; 1984; 64(2):134-9. PubMed ID: 6203301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Antipsoriatic effect of dithranol (anthralin). 1].
    Raab W
    Hautarzt; 1975 Sep; 26(9):452-5. PubMed ID: 1184389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hyperreactivity to dithranol--irritation or allergy?].
    Lohrisch I; Haustein UF; Neumann JH
    Dermatol Monatsschr; 1986; 172(5):266-71. PubMed ID: 3721032
    [No Abstract]   [Full Text] [Related]  

  • 8. Irritation and staining by dithranol (anthralin) and related compounds. III. Cumulative irritancy and staining during repeated chamber testing.
    Brandt H; Mustakallio KK
    Acta Derm Venereol; 1983; 63(3):237-40. PubMed ID: 6192640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Woronoff ring during anthralin therapy for psoriasis.
    Gupta AK; Ellis CN; Goldfarb MT; Voorhees JJ
    Arch Dermatol; 1986 Mar; 122(3):248. PubMed ID: 3954390
    [No Abstract]   [Full Text] [Related]  

  • 10. Anthralin: historical and current perspectives.
    Ashton RE; Andre P; Lowe NJ; Whitefield M
    J Am Acad Dermatol; 1983 Aug; 9(2):173-92. PubMed ID: 6309924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. On the stability of some antipsoriatic active anthralin (dithranol) derivatives.
    Schaltegger A; Bloch U; Krebs A
    Dermatologica; 1982 Oct; 165(4):363-8. PubMed ID: 7152072
    [No Abstract]   [Full Text] [Related]  

  • 12. Relationship between skin type and erythemal response to anthralin.
    Maurice PD; Greaves MW
    Br J Dermatol; 1983 Sep; 109(3):337-41. PubMed ID: 6615720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short contact anthralin therapy of psoriasis with and without UV-irradiation and maintenance schedule to prevent relapses.
    Brun P; Juhlin L; Schalla W
    Acta Derm Venereol; 1984; 64(2):174-7. PubMed ID: 6203312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toxicologic study of anthralin in an aqueous cream formulation.
    Neill SM; Bugrein A; Coulson IH; Greaves MW
    Cutis; 1984 Dec; 34(6):563-6. PubMed ID: 6518819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Current state and prospects of the use of cygnoline in the treatment of psoriasis].
    Ciesielska J
    Przegl Dermatol; 1985; 72(1):77-90. PubMed ID: 3892593
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of coal tar on cutaneous aryl hydrocarbon hydroxylase induction and anthralin irritancy.
    Lawrence CM; Finnen MJ; Shuster S
    Br J Dermatol; 1984 Jun; 110(6):671-5. PubMed ID: 6733038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Reduction of erythema by the addition of bituminous coal tar in anthralin short-term therapy].
    Heller G
    Dermatol Monatsschr; 1985; 171(11):718-20. PubMed ID: 4085670
    [No Abstract]   [Full Text] [Related]  

  • 18. [Antipsoriatic effect of dithranol (anthralin). 2].
    Raab W
    Hautarzt; 1975 Sep; 26(9):456-9. PubMed ID: 1102494
    [No Abstract]   [Full Text] [Related]  

  • 19. Irritancy of anthralin in patients with psoriasis and widespread vitiligo.
    Roberts DL
    Br J Dermatol; 1984 Feb; 110(2):247-8. PubMed ID: 6696841
    [No Abstract]   [Full Text] [Related]  

  • 20. [Suppression of cignolin-induced erythema by tar].
    Schulze HJ
    Z Hautkr; 1984 May; 59(10):659-62. PubMed ID: 6741205
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.